A Comparison of the Interactions of Dihydroergotamine, Ergotamine and GR 43175 with 5-HT1 Receptor Subtypes
- 1 October 1989
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 9 (10_suppl) , 340-341
- https://doi.org/10.1177/0333102489009s10181
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- POSSIBLE BENEFIT OF GR43175, A NOVEL 5-HT1-LIKE RECEPTOR AGONIST, FOR THE ACUTE TREATMENT OF SEVERE MIGRAINEThe Lancet, 1988
- A Controlled Study of Dihydroergotamine in the Treatment of Acute Migraine HeadacheHeadache: The Journal of Head and Face Pain, 1986